PT-141
10 mg
Bremelanotide
PT-141
Selective MC4R agonist for sexual function pathway research.
Prices in AUD. Tax included.
Research Use Only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Description
PT-141 (Bremelanotide) is a synthetic melanocortin peptide derived from Melanotan II, engineered for selectivity at the MC4R receptor. Unlike PDE5 inhibitors which act peripherally on vascular smooth muscle, PT-141 acts centrally via hypothalamic melanocortin pathways, making it unique for studying CNS-mediated sexual arousal mechanisms.
Specifications
- SKU
- PT141-10MG
- Size
- 10 mg
- Form
- Lyophilised Powder
- Purity
- >99%
- Storage
- -20°C (lyophilised), 2-8°C (reconstituted)
- Shipping
- Australia Post — 3–5 business days
Research Summary
Studies demonstrate PT-141 activates MC4R receptors in the hypothalamus, triggering downstream dopaminergic signaling in the medial preoptic area. Unlike Melanotan II, it has minimal MC1R activity (reduced pigmentation effects). Preclinical research shows efficacy in both male and female models of sexual dysfunction.
Testing Protocol
- HPLC Purity Analysis
- Mass Spectrometry Identity Verification
- Endotoxin Screening (LAL Test)